Caller alleged discrepant inratio results.Results as follows: date, inratio, lab: (b)(6) 2014, 6.8, -; (b)(6) 2014, 3.2, -; (b)(6) 2014, 1.8, 1.3; (b)(6) 2015, 4.8, 3.1.Time between tests on (b)(6) 2015: 15 minutes after inratio.Therapeutic range: 3-4.Customer also reports that his therapeutic range has been stable between 3.2 and 3.6.The patients previscan dose was decreased on (b)(6) from 1 to 1/2 for four days.On (b)(6) the inratio result was 3.2 and treatment was maintained at 1/2.On (b)(6) the patient presented with chest pain and shortness of breath; patient was hospitalized and given an injection of heparin.Patient stated he was "ok" and was released from the hospital.
|
The customer reported a discrepant high inratio inr result during testing.It is indicated that product is not returning for evaluation.Since the product associated with the complaint was not returned, a review of in-house testing data was performed.Retain strip testing results met both accuracy and repeatability criteria.The product performed as expected and no product deficiencies were observed.Impedance curve analysis was not performed because the meter associated with the complaint was not returned.A review of the manufacturing records for the lot did not uncover any non-conformances.Lot meets release specification.Root cause could not be determined from the information provided by the customer.Based on the information available, there is no indication of a product deficiency.No corrective action is required at this time.
|